280 related articles for article (PubMed ID: 36773106)
21. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
22. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
[TBL] [Abstract][Full Text] [Related]
26. Retinal arterial Aβ
Shi H; Koronyo Y; Fuchs DT; Sheyn J; Jallow O; Mandalia K; Graham SL; Gupta VK; Mirzaei M; Kramerov AA; Ljubimov AV; Hawes D; Miller CA; Black KL; Carare RO; Koronyo-Hamaoui M
Alzheimers Dement; 2023 Nov; 19(11):5185-5197. PubMed ID: 37166032
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
28. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
30. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
31. Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications.
Wang L; Mao X
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33653000
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.
Koronyo Y; Salumbides BC; Black KL; Koronyo-Hamaoui M
Neurodegener Dis; 2012; 10(1-4):285-93. PubMed ID: 22343730
[TBL] [Abstract][Full Text] [Related]
33. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.
Shi H; Koronyo Y; Fuchs DT; Sheyn J; Wawrowsky K; Lahiri S; Black KL; Koronyo-Hamaoui M
Acta Neuropathol Commun; 2020 Nov; 8(1):202. PubMed ID: 33228786
[TBL] [Abstract][Full Text] [Related]
34. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
36. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
37. Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation.
Wang MD; Zhang S; Liu XY; Wang PP; Zhu YF; Zhu JR; Lv CS; Li SY; Liu SF; Wen L
Acta Pharmacol Sin; 2023 Nov; 44(11):2151-2168. PubMed ID: 37420104
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS).
Liu Z; Shi D; Cai Y; Li A; Lan G; Sun P; Liu L; Zhu Y; Yang J; Zhou Y; Guo L; Zhang L; Deng S; Chen S; Yu X; Chen X; Zhao R; Wang Q; Ran P; Xu L; Zhou L; Sun K; Wang X; Peng Q; Han Y; Guo T
Alzheimers Res Ther; 2024 Apr; 16(1):84. PubMed ID: 38627753
[TBL] [Abstract][Full Text] [Related]
39. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
40. Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta.
Simons ES; Smith MA; Dengler-Crish CM; Crish SD
Neurobiol Dis; 2021 Jan; 147():105146. PubMed ID: 33122075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
